8106 — Shenghua Lande Scitech Income Statement
0.000.00%
Last trade - 00:00
- HK$35.46m
- HK$31.84m
- CNY98.09m
- 11
- 59
- 46
- 28
R2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 285 | 238 | 206 | 135 | 98.1 |
Cost of Revenue | |||||
Gross Profit | 31.2 | 40.6 | 40.6 | 15.8 | 11.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 281 | 232 | 198 | 154 | 140 |
Operating Profit | 4.55 | 5.85 | 8.46 | -18.9 | -41.7 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 3.85 | 5.68 | 8.47 | -19.2 | -42.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.72 | 5.92 | 7.55 | -19 | -42.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 4.61 | 5.03 | 0.665 | -16.2 | -42.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4.61 | 5.03 | 0.665 | -16.2 | -42.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.011 | 0.011 | 0.013 | -0.038 | -0.082 |